Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)

CAPS Rating: 4 out of 5

A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.

Recs

1
Player Avatar STAINEDGLASSER (72.76) Submitted: 2/6/2012 1:17:09 PM : Outperform Start Price: $16.39 MNTA Score: -14.29

They have a patent on a generic version of Lovenox. Last week the company was blocked by a federal appeals court from marketing their product. If their patents are upheld, their revenues will skyrocket. Lovenox is used to prevent blood clots, post surgery.

Featured Broker Partners


Advertisement